2015
Nephrogenic Systemic Fibrosis
LaChance A, Abu-Alfa A, Cowper S. Nephrogenic Systemic Fibrosis. 2015, 119-136. DOI: 10.1007/978-1-4939-2395-3_12.ChaptersNephrogenic systemic fibrosisMagnetic resonance angiographySystemic fibrosisNon-renal patientsOff-label useDiverse medical specialtiesMedication toxicityRenal diseasePathological featuresRenal populationRare conditionUnsuspected conditionsLong-term effectsNew toxicitiesGadolinium retentionResonance angiographyDisease causesTreatment climateNovel diseaseMedical specialtiesFibrosisDiseasePhysiciansPharmaceutical companiesToxicity
2007
Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor
Moreno‐Romero J, Segura S, Mascaró JM, Cowper SE, Julià M, Poch E, Botey A, Herrero C. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor. British Journal Of Dermatology 2007, 157: 783-787. PMID: 17627792, DOI: 10.1111/j.1365-2133.2007.08067.x.Peer-Reviewed Original ResearchConceptsNephrogenic systemic fibrosisDevelopment of NSFRenal insufficiency patientsOnset of symptomsNephrogenic fibrosing dermopathyPossible aetiological factorsMagnetic resonance angiographyRenal diseaseCase seriesAetiological factorsSystemic fibrosisResonance angiographyFibrotic conditionsPatientsParamagnetic contrast agentHistory of useDiseaseContrast agentsAngiographyFibrosisDermopathyEtiologyGadoliniumSymptoms